FOLD logo Amicus Therapeutics : FOLD

FOLD

Stock Data

$9.48

Change up

$0.10 (1.01%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Amicus Therapeutics Inc is a biotechnology firm dedicated to tackling rare diseases. It's known for Galafold, an innovative oral treatment for adults with Fabry disease, a genetic disorder. The company also works on developing therapies for other conditions, including through partnerships like those with the University of Pennsylvania and GlaxoSmithKline. Founded in 2002 and based in Princeton, New Jersey, Amicus Therapeutics strives to bring precision medicine to those facing life-altering diagnoses.

All Amicus Therapeutics Articles

11 Articles

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio